Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics
Zehan Chen(Xi'an University of Technology), Haiying Zhang(Liaoning University of Traditional Chinese Medicine)
Cited by 129
Related Papers
Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents
|Journal of Biological Chemistry|2003|382
1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2)
|Journal of Biological Chemistry|2011|117
Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase–activated protein kinase 2 in mediating DNA damage–induced cell cycle arrest: implications for cancer therapy
|Molecular Cancer Therapeutics|2006|94
Optimization of ultracentrifugation‐based method to enhance the purity and proteomic profiling depth of plasma‐derived extracellular vesicles and particles
|Journal of Extracellular Biology|2024|6